Federal enforcement against CBD medical claims in the US is going strong, with the Federal Trade Commission (FTC) recently sending a warning letter to a new company about what it said were prohibited medical claims
Submit your access request to explore how it can streamlines access to critical cannabis insights
"*" indicates required fields